The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Mohamed Tausif Siddiqui, MD: Comparing Tunneled Catheters with PICCs
Tunneled catheters resulted in lower rates of deep vein thrombosis when compared to PICCs.
Study Finds Increased CDI Incidence, Mortality Rates in Urban Teaching Hospitals
The findings also showed that large bedded hospitals trended towards higher clostridium difficile infection incidence and mortality rates.
Biologic Use Linked to a Drop in Colectomies for IBD Patients
Over the course of the 19 year review, biologic use has increased, while the prevalence of colectomies has decreased.
Vedolizumab Shows Real-World Efficacy Against Ulcerative Colitis, Crohn's Disease
A new study demonstrates that vedolizumab is associated with real-world corticosteroid-free response and remission in patients with ulcerative colitis and Crohn’s disease.
Federal Centers Crucial for Hepatitis C Continuum of Care
In a study presented at ACG, investigators find the rate of confirmed HCV infections remained stable pre- and post-interventions.
Brooks Cash, MD, FACG: Gastrointestinal Risks in Patients with Diabetes
Brooks Cash, MD, discusses the importance of bowel preparation and surveillance in patients with diabetes.
IBD Treatment Linked to Lower Risk of Myocardial Infarctions
Anti-TNFs, vedolizumab, ustekinumab, thiopurines, and 5-ASA were all linked to a lower risk of myocardial infarctions.
CDI Rates Low Among Tofacitinib-Treated Ulcerative Colitis Patients
A poster presented at ACG provides an updated analysis of clostridium difficile infection in the tofacitinib UC clinical program.
James Church, MD: Combination Therapy for Colorectal Cancer
Sulindac and eflornithine could help delay the need for lower gastrointestinal surgery for FAP patients.
Brooks Cash, MD, FACG: NER1006 for Bowel Preparation in Diabetes Patients
New data presented at ACG 2020 shows NER1006 bowel preparation to be safe and efficacious in patients with diabetes preparing for their colonoscopy.
Mirikizumab Shows Efficacy Treating Crohn’s Disease
Researchers test 3 different doses of mirikizumab in both biologic experienced and naïve Crohn’s disease patients.
Girish Hiremath, MD, MPH: Pediatric Compliance to EoE Therapies
An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.
Maria T. Abreu, MD: Ustekinumab Improves Quality of Life for Ulcerative Colitis Patients
Ustekinumab resulted in a reduction of both stool frequency and rectal bleeding for ulcerative colitis patients.
Chronic Liver Disease Plus Influenza Linked to Increased Inpatient Burden
New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.
New Study Looks at Response Rate of Tofacitinib in Ulcerative Colitis
More than half of the patient population achieved a defined response at both day 14 and week 6.
Evan S. Dellon, MD, MPH: Dupilumab Shows Promise Treating Eosinophilic Esophagitis
Research shows dupilumab remains effective in EoE for up to 2 years.
Vedolizumab Associated with Ulcerative Colitis Control and Maintenance
A new study presented at ACG shows vedolizumab to be superior to adalimumab in maintaining early disease control in patients with moderate-to-severe ulcerative colitis.
New Data Looks at Link Between C. Diff Infections and Irritable Bowel Syndrome
In data presented at ACG, investigators found a link between sex, lower BMI, and the development of irritable bowel syndrome in patients following a c. diff infection.
Ustekinumab Reduces Rectal Bleeding in Ulcerative Colitis Patients
In a poster presented during ACG, investigators show data from a long-term extension of the UNIFI trial.
Study Shows Opioid Dependence Has No Impact on TPIAT Outcomes
Patients with chronic pancreatitis can exhibit dependence on chronic opioid therapy prior to receiving total pancreatectomy with islet autotransplantation.
Mitigating Unnecessary Isolation Due to Suspected C. Diff Infection
Isolation as a result of suspected C. Diff can take a significant financial toll on the healthcare system, thus it is necessary to determine appropriate factors that can predict CDI.
Chester Oddis, MD: Myositis, Diagnosis and Management Challenges
An expert discusses the difficulties in diagnosing and managing myositis, as well as how the COVID-19 pandemic has affected clinical care.
Daniel Albert, MD: Telemedicine Challenges for Rheumatologists During COVID-19
Three key issues with using the technology over in-person visits.
Jeffrey Curtis, MD, MS, MPH: The Future of Rheumatological Care
Care of rheumatic patients must factor in cradiovascular risk and conditions.
Lisa Sammaritano, MD: Final Thoughts, ACR Guidelines on Reproductive Health
The recently published American College of Rheumatology guidelines on reproductive health is a great resource for rheumatologists.
Daniel Albert, MD: Telemedicine for Rheumatic Care
How rheumatologists use telemedicine during COVID-19.
Alan Kaye, MD, PhD: Treating Pain During COVID-19
Leveraging telemedicine during COVID-19.
Jeffrey Curtis, MD, MS, MPH: The Responsibility of Cardiovascular Risk Management in Rheumatology
An expert discusses the role of the rheumatologist in managing cardiovascular risk factors as well as current gaps in the field.
Alan Kaye, MD, PhD: The Intersection of Pain and Rheumatology
An expert explains resources for pain related to rheumatic conditions.
Randall Cron, MD, PhD: Multisystem Inflammatory Syndrome in Children
MIS-C is a condition recently recognized in children with COVID-19.